0001181431-12-008787.txt : 20120214
0001181431-12-008787.hdr.sgml : 20120214
20120214172525
ACCESSION NUMBER: 0001181431-12-008787
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120210
FILED AS OF DATE: 20120214
DATE AS OF CHANGE: 20120214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Caballa Susan
CENTRAL INDEX KEY: 0001489530
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34703
FILM NUMBER: 12612883
MAIL ADDRESS:
STREET 1: 6120 WINDWARD PARKWAY
STREET 2: SUITE 290
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALIMERA SCIENCES INC
CENTRAL INDEX KEY: 0001267602
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 6120 WINDWARD PARKWAY
STREET 2: STE 290
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
BUSINESS PHONE: 6789905740
MAIL ADDRESS:
STREET 1: 6120 WINDWARD PARKWAY
STREET 2: STE 290
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
4
1
rrd334155.xml
FORM 4
X0304
4
2012-02-10
0
0001267602
ALIMERA SCIENCES INC
ALIM
0001489530
Caballa Susan
6120 WINDWARD PARKWAY, SUITE 290
ALPHARETTA
GA
30005
0
1
0
0
SVP,Regulatory&Medical Affairs
Employee Stock Option (Right to Buy)
1.65
2012-02-10
4
A
0
60000
0
A
2022-02-09
Common Stock
60000
60000
D
Employee Stock Option (Right to Buy)
1.65
2012-02-10
4
A
0
25000
0
A
Common Stock
25000
25000
D
This option shall vest in forty-eight equal monthly installments beginning on March 10, 2012.
This option shall vest in full upon receipt by the Issuer, on or prior to August 9, 2013, of approval from the U.S. Food and Drug Administration of the Issuer's New Drug Application for ILUVIEN (the "Vesting Event").
This option shall expire on February 9, 2022, if the Vesting Event occurs. If the Vesting Event does not occur, then the option will expire on August 10, 2013.
/s/ Susan H. Caballa
2012-02-13